Skip to main content
Clinical Trials/NL-OMON44377
NL-OMON44377
Completed
Not Applicable

Perioperative Management of Patients who are Receiving a Novel Oral Anticoagulant (Dabigatran, Rivaroxaban or Apixaban) and Require an Elective Surgery or Medical Procedure: A Prospective Cohort Study (PAUSE)* - PAUSE study

Academisch Medisch Centrum0 sites20 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Perioperative Use of Anticoagulantia for Surgery Evaluation
Sponsor
Academisch Medisch Centrum
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- age \> 18 years
  • \- receiving a NOAC (dabigatran or rivaroxaban or apixaban) for stroke prevention for Atrial Fibrillation (SPAF)
  • \- ability to adhere to the NOAC discontinuation protocol
  • \- patient will be undergoing any elective surgical procedure or intervention

Exclusion Criteria

  • \- CrCl \<30 mL/min for dabigatran\- and rivaroxaban\-treated patients (\<25 mL/min for apixaban\-treated patients) as estimated by Cockroft\-Gault formula
  • \- Cognitive impairment or psychiatric illness that precludes collection of follow\-up data
  • \- Inability or unwillingness to provide informed consent
  • \- Previous participation in this study having had a surgery/procedure performed

Outcomes

Primary Outcomes

Not specified

Similar Trials